#24-419 Delisting of Derivatives from NGM
Reading Time: < 1 minute Information about certain derivatives that will be delisted from NGM. For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market
Fondia Plc: Share repurchase 5.12.2024
Reading Time: < 1 minute Fondia Plc Company release 5.12.2024 at 6.45 p.m. EET Fondia – Acquisition of own shares 5.12.2024 Fondia Plc First North Finland Date 5.12.2024 Exchange transactions Buy Share class FONDIA Amount, shares 977 Average price/share, EUR 4,913060
Pricer has successfully issued bonds of SEK 300 million and exercises its right to voluntary early redemption of its existing bonds
Reading Time: 3 minutes NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS, ANY STATE OF THE
Observe Medical ASA: Final result of the subsequent offering and allocation of shares; Updated amendments of loans from Navamedic ASA to be implemented including partial conversion to shares
Reading Time: 7 minutes NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT
Hansa Biopharma Completes Enrolment in Global Pivotal Phase 3 Trial of imlifidase in Anti-Glomerular Basement Membrane Disease
Reading Time: 4 minutes Data from the trial is expected to be shared in 2025 Lund, Sweden, 5 December 2024. Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA) today announced it has completed the enrolment of patients in the GOOD-IDES-02 trial, a global pivotal Phase 3 trial
Belden Debuts New Corporate Brand Platform
Reading Time: 2 minutes Belden Inc. St. Louis, United States: Belden Inc. (NYSE: BDC), today revealed a new corporate brand identity that underscores the company’s transformation to a comprehensive network and data infrastructure solutions provider. These solutions play a pivotal role in addressing automation and
Blue Dart Launches Affiliate Program to Drive Innovation in Logistics for Technology Partners
Reading Time: 3 minutes Blue Dart, South Asia’s leading express air and integrated transportation company, announces the launch of its first-of-its-kind Blue Dart Affiliate Program (BDAP) for technology partners and ecosystem enablers. This innovative program is designed to foster collaboration with top technological enablers in the industry, offering seamless
Form 8.3 – Britvic plc
Reading Time: 3 minutes FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Magnetar Capital Partners LP (b) Owner
RSA Recognized in 2024 Gartner® Magic Quadrant™ for Access Management
Reading Time: 3 minutes Burlington, Mass., United States: RSA, the security-first identity leader, announced today that RSA® ID Plus, the world’s most secure identity and access management (IAM) platform has been named a Niche Player in the 2024 Gartner® Magic Quadrant™ for Access Management.
Heimdal Announces New Partnership with ITHealth to Reinforce Cyber Security for NHS Organisations
Reading Time: 3 minutes LONDON, United Kingdom, 5 December 2024 – Heimdal, a global leader in proactive cyber security solutions, announces a new partnership with ITHealth, a trusted cyber security provider to the NHS. This partnership expands ITHealth’s offerings by integrating Heimdal’s advanced capabilities into